PARP1 and colorectal carcinoma: Recently, a study revealed that PARP-1 seems to protect against the carcinogenic process but once it is initiated, PARP-1 expression facilitates tumour progression [11,15], indicating that this protein acts as a double-edged sword in CRC, suppressing tumour initiation but promoting inflammation-driven tumour progression [15].